BioSpace News Archive

There is a growing demand for handheld imaging devices in dentistry and orthopedics.

The global hospital infection therapeutics market was valued at US$ 14.4 Bn in 2017 and is projected to expand at a significant CAGR of 2.4% from 2018 to 2026.

The global mHealth monitoring diagnostic medical devices market for the historical period 2017–2018 and forecast period 2019–2027, rise in prevalence of chronic disorders, aging population, technological advancements, entry of new players, and increase in access to health care are projected to drive the global mHealth monitoring diagnostic medical devices market.

This report analyzes the current scenario and future growth prospects of the global viral vector & plasmid DNA manufacturing market.

Paratek Pharmaceuticals, Inc. announced that on April 29, 2022, the Company granted stock options to one new employee of the Company.

eFFECTOR Therapeutics, Inc. announced that the management team will participate in and host 1x1 meetings at the following upcoming investor conferences:

Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today reported financial results for the first quarter of 2022 and business highlights.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) today announced that it will release financial and operational results for first quarter 2022 on Tuesday, May 10, 2022, before markets open.

The vital signs monitoring systems market is expected to witness strong growth over the forecast period.

Ambrx Biopharma Inc., or Ambrx announced that it filed its annual report on Form 20-F for the year ended December 31, 2021 with the U.S. Securities and Exchange Commission on April 26, 2022.